Cerecin received US FDA clearance to study CER-0001 under an Investigational New Drug…
The authorization of the IND for Infantile Spasms (IS) is the third for tricaprilin, with other INDs open in Alzheimer’s disease and migraineA pilot study of CER-0001 in IS is ongoing in…